Reflect Scientific (Reflect Scientific) Risk Assessment

View and export this data going back to . Start your Free Trial

What is Reflect Scientific Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Reflect Scientific is: No Data: Cannot be evaluated.

Competitive Comparison of Reflect Scientific's Risk Assessment

For the Medical Instruments & Supplies subindustry, Reflect Scientific's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Reflect Scientific's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Reflect Scientific's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Reflect Scientific's Risk Assessment falls into.

Reflect Scientific (OTCPK:RSCF) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Reflect Scientific Risk Assessment Related Terms

Thank you for viewing the detailed overview of Reflect Scientific's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Reflect Scientific (Reflect Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Reflect Scientific Inc (OTCPK:RSCF) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

1266 South 1380 West, Orem, UT, USA, 84058

Website

https://www.reflectscientific.com

Reflect Scientific Inc is engaged in the manufacture and distribution of products targeted at the life science market. The company serves a varies array of customers including hospitals and diagnostic laboratories, pharmaceutical and biotech companies, universities, government and private sector research facilities, and chemical and industrial companies. The products of the company are Cryometrix Freezers which provides energy savings and other critically important benefits to cryo-storage customers in the Life Science related industries, and detectors that serve the analytical instrumentation sector of the Life Sciences market. The company sells its products in the biotechnology, pharmaceutical, and medical industries.

Executives

Kim Boyce	director, 10 percent owner, officer: President	1266 SOUTH 1380 WEST, OREM UT 84058
Keith L Merrell	officer: CFO	1240 MUELLER PARK ROAD, BOUNTIFUL UT 84010
William G Moon	director	1266 SOUTH 1380 WEST, OREM UT 84058
David Scott Strate	officer: CFO	1270 S 1380 W, OREM UT 84058
Kevin Cooksy	officer: Secretary Treasurer	3161 GRANADA DRIVE, CAMERON PARK CA 95682
Craig Morrison	director	975 NORTH TERRACE DRIVE, PROVO UT 84604
Thomas A Tait	director, officer: Vice President	514 AMERICAS WAY #5556, BOX ELDER SD 57719